07:00 , Oct 29, 2015 |  BC Innovations  |  Product R&D

Qureing antibiotic resistance

QureTech Bio AB is targeting chlamydia and tuberculosis with compounds that disable, rather than kill, pathogens to circumvent antibiotic resistance. By targeting the organisms' virulence factors, the company hopes to spare the host flora and...